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Interferon-a Alters Spectrin Organization in Normal and Leukemic Human B Lymphocytes
By Sharon S. Evans, Wan-Chao Wang, Carol C. Gregorio and type I1 (IFN-y), bind to distinct cell surface receptors and elicit common and unique biologic effects. IFN-a has been shown in clinical trials to be highly effective in the treatment of B-cell lymphoproliferative diseases including hairy cell leukemia (HCL) and early stage chronic lymphocytic leukemia (CLL).2,3 These diseases are characterized by the presence in the blood of clonally derived malignant B lymphocytes that have an impaired capacity to re~irculate.~ Recent studies suggest that the clinical response to IFN-a in HCL and CLL results, in part, from a direct effect of this cytokine on neoplastic B-cell growth, differentiation, and recirculation. We and other investigators have shown that exposure of leukemic B cells from HCL patients to IFN-a either in vitro or in vivo inhibits B-cell growth factor (BCGF)-dependent pr~liferation,~-' suggesting that IFN-a directly regulates the clonal expansion of B-HCL cells in vitro. Moreover, IFN-a has been shown to induce the differentiation of normal and malignant B cells in vitro as assessed by transformation to a plasmacytoid morphology and increased synthesis and secretion of Ig. 839 Finally, responsiveness to IFN-a therapy in HCL and CLL patients is associated with a rapid reduction in the number of circulating leukemic B It has been speculated that these observations reflect a direct effect of IFN-a on the recirculation of neoplastic B cells because IFNa has been shown to increase normal lymphocyte uptake and retention in lymph nodes in several animal models.'O~'' Cytoskeletal proteins play an integral role in maintaining cytoplasmic and membrane organization as well as in mediating active cellular responses including adhesion, motility, and receptor-mediated activities. Thus, it is of interest that B-CLL and B-HCL cells are characterized by abnormalities that suggest defects in cytoskeletal function. Specifically, B-CLL cells have lower motility and a decreased ability to cap surface Ig compared with normal B lymphocytes, whereas B-HCL cells exhibit abnormal microfilamentous plasma mem- known regarding the effects of IFN-a on the organization of cytoskeletal proteins in freshly isolated normal and leukemic B cells in vitro or whether changes in cytoskeletal protein organization or rate of synthesis are involved in the therapeutic effects of IFN-a.
The present study was undertaken to investigate the effect of IFN-a on the cytoskeletal protein spectrin in normal human B lymphocytes and in leukemic B cells isolated from the peripheral blood of HCL and CLL patients. We have been interested in the immunologic role of spectrin in murine and human lymphocytes since we observed that the subcellular distribution of this protein appears to be dynamic and is affected by signaling of the antigen receptor or by phorbol esters and other treatment^.".^' Further, we have recently linked these changes in spectrin distribution to the activation and positioning of protein kinase C (PKC). 2' In this report, freshly isolated normal and leukemic B cells were found to exhibit a diffuse fluorescence pattern when immunostained for spectrin. Exposure of normal and leukemic B cells to IFN-a in vitro consistently resulted in the formation of discrete focal accumulations of spectrin, as well as an increase in the total cellular content of spectrin. These results are discussed in view of the known functional aspects of spectrin distribution in lymphocytes. HCL and CLL patients selected for this study had not been treated with chemotherapy regimens for 4 months and had peripheral white blood cell (WBC) counts >20 X I 03/mm3. Peripheral blood mononuclear cells (PBMC) were isolated from the venous blood of normal donors and patients by FicollHypaque density gradient centrifugation, as previously de~cribed.~.~ Results are reported only for malignant cell populations that expressed cell surface phenotypes consistent with B-CLL (>90% CD19+CD5+) and B-HCL (>90% CDI lc+CD22+) and contained less that 5% CD3+ T cells or CD14' monocytes. Normal donor PBMC were routinely -10% CD 19+, 70% CD3+, and 20% CD 14+. Normal and malignant lymphocytes were cultured for the indicated time periods at a density of 2 X IO6 cells/mL in RPMI 1640 containing 10% heat-inactivated fetal calf serum (FCS) (GIBCO Laboratories, Grand Island, NY), 100 U/mL penicillin, 100 pg/mL streptomycin, and 2 mmol/L Lglutamine. Analysis of spectrin localization was performed only on freshly isolated lymphocytes because reproducible results could not be obtained using cryopreserved samples.
Immunolocalization of spectrin at the light microscope level was performed as described p r e v i o~s l y . '~.~~ Briefly, lymphocytes were washed in phosphate-buffered saline (PBS) and allowed to settle onto glass coverslips pretreated with Alcian Blue (Sigma Co, St Louis, MO) to promote adhesion. Adherent cells were fixed in 2% formaldehyde, washed in PBS, and permeabilized in 0.5% Triton X-IOO/PBS (PBS/Triton). Cells were then incubated with rabbit anti-spectrin antibodies (diluted I :75 in PBS/Triton), washed multiple times in PBS and incubated with FITC-conjugated goat anti-rabbit IgG (diluted 1: I50 in PBS/Triton) for 30 minutes. Spectrin distribution patterns were quantified in a total of 500 cells per experimental group. For the purposes of this study, focal accumulations of spectrin are defined by immunofluorescence localized in distinct aggregates or crescent-shaped caps and are easily discriminated from diffuse patterns. Secondary antibodies alone, or used in combination with pre-immune sera, consistently showed negligible fluorescence.
The distribution of spectrin in B and T lymphocytes from normal donors was examined by costaining lymphocytes with anti-spectrin antibodies in combination with either anti-CD3 or anti-Ig MoAbs. Briefly, cells were first allowed to adhere to Alcian blue-coated coverslips, fixed with 2% formaldehyde to prevent antibody-induced redistribution of cytoskeletal proteins, and then labeled with FITCconjugated murine MoAbs specific for either human Ig or CD3. Cells were then permeabilized in 0.5% Triton X-IOO/PBS, and immunostained with rabbit-anti-spectrin antibody and TRITC-conjugated goat anti-rabbit IgG. Spectrin distribution was quantified in 500 total CD3+ T cells or Ig+ B cells.
Cells were prepared for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis as described p r e v i o~s l y .~~~~~ Briefly, cells were washed in PBS containing 1 mmol/L PMSF and extracted with 9.2 mol/L urea for 45 minutes at room temperature, sonicated,
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and centrifuged for 10 minutes at 16,000gin an Eppendorfcentrifuge. Relative protein concentrations were determined using the Biorad protein assay (Bio-Rad Lab, Richmond, CA). Samples were solubilized in I % SDS, 125 mmol/L Tris-HCL, pH 6.8, 10% glycerol, I% 0-mercaptoethanol, 1 mmol/L EDTA, and 0.004% bromophenol blue and boiled for 3 minutes. Duplicate samples (30 p g per lane) were run on 10% SDS-polyacrylamide gels and then either stained with Coomassie blue or electrophoretically transferred to nitrocellulose paper. The nitrocellulose blot was incubated with rabbit anti-spectrin antiserum (I: 1,000) followed by peroxidase-conjugated goat antirabbit IgG (I: 1,000; Boehringer Mannheim, Indianapolis, IN). a Spectrin was visualized by incubating the blot in 4chloro-I-naphthol dissolved in methanol (3.0 mg/mL) and diluted 1:5 with Tris-buffered saline containing 0.005% hydrogen peroxidase. Scanning densitometry analysis of immunoblots was performed on a Molecular Dynamics Fast Scan (Molecular Dynamics, Sunnyvale, CA).
RESULTS
IFN-a alters the subcellular distribution of spectrin in hum a n leukemic and normal B cells. Mononuclear cells from
B-cell leukemia patients and normal donors were immunostained for spectrin immediately after their isolation from the peripheral blood or following incubation in the presence or absence of recombinant human IFN-a. Indirect immunofluorescence analysis of neoplastic cells from two CLL patients (Fig l , a and d) indicated that greater than 90% of peripheral blood B-CLL cells constitutively exhibit a diffuse fluorescence pattern of spectrin. Culture of B-CLL cells for 24 hours in medium containing 10% FCS resulted in a slight increase in heterogeneity among cells with respect to spectrin distribution (Fig 1, b and e) . However, a marked change in the subcellular distribution of spectrin was observed in B-CLL cells after incubation with IFN-a at 1,000 IU/mL such that there was a loss of the diffuse staining pattern and a concomitant increase in the number of cells exhibiting distinct focal accumulations of spectrin (Fig 1, c and f) . Notable differences were observed in the type of focal accumulation that occurred in B-CLL cells from these two patients after exposure to IFN-a. Specifically, IFN-a induced the formation of either aggregate or caplike configurations near the plasma membrane in -45% of B-CLL cells from one patient (Fig IC) , whereas spectrin was found predominantly in discrete aggregates in -77% of B-CLL cells from a second patient (Fig If) .
Freshly isolated leukemic B cells from the peripheral blood of an HCL patient were also found to exhibit a diffuse intracellular localization of spectrin (Fig 2a) , comparable with the staining pattern observed in B-CLL cells. Incubation for 24 hours in culture medium containing 10% FCS alone had negligible effects on the distribution of spectrin in B-HCL cells from this patient (Fig 2b) , whereas incubation in the presence of 1,000 IU/mL of IFN-a resulted in the formation of both aggregates or caplike structures of spectrin in approximately 60% of B-HCL cells (Fig 2c) . In the studies shown in Figs I and 2, lymphocytes were immunostained for spectrin after their attachment to Alcian blue-coated glass coverslips, as previously de~cribed.".'~ Identical results were obtained when lymphocytes were immunostained for spectrin in suspension (data not shown), indicating that focal accumulations of spectrin in IFN-treated cells were not formed as a result of adhesion to a glass substrate. Table I use indicate that a majority of normal peripheral blood B and T lymphocytes exhibited a diffuse spectrin staining pattern while incubation of lymphocytes for 24 hours in culture medium alone increased the number of cells exhibiting caplike accumulations of spectrin to a variable extent. IFN-a at a concentration of 200 IU/mL markedly increased the presence of focal accumulations of spectrin in the B-cell populations of four normal donors, while IFN-a had only a moderate effect on spectrin organization in T cells. Taken together, these results indicate that IFN-a alters the intracellular dis- * The subcellular organization of spectrin was determined by immunofluorescence microscopy immediately after isolation of lymphocytes from the peripheral blood (0 hours) or after incubation for 24 hours in the absence or presence of 200 IU/mL of IFN-a tribution of spectrin in both normal and neoplastic B lymphocytes.
Dose dependence and kinetics of IFN-a-induced reorganization of spectrin.
To determine the effect of IFN-a concentration on the intracellular localization of spectrin, B-CLL cells from two CLL patients were incubated with increasing concentrations of IFN-a for 24 hours and then immunostained with anti-spectrin antibodies. The results shown in Fig 4 show that IFN-a acted in a dose-dependent manner to cause the formation of discrete focal accumulations of spectrin. Moreover, low IFN-a concentrations (ie, 10 to 100 IU/ mL) increased the focal accumulations of spectrin, suggesting that spectrin reorganization in leukemic B cells occurs at both physiologic and pharmacologic concentrations of IFNa. It is of interest that similar results were obtained in repeat experiments performed at a 1 -month interval using freshly isolated maiignant B lymphocytes from the same CLL patient (Fig 4) .
B-CLL cells from two patients were incubated with 200 IU/mL IFN-a for various periods of time to determine the kinetics of IFN-a-induced spectrin reorganization (Fig 5) . A slight change in spectrin distribution could first be observed 6 hours following the addition of IFN-a while more marked effects on spectrin distribution were evident after incubation for greater than 18 hours. The presence of spectrin in a concentrated region of the cell is maintained for up to 48 hours during continuous exposure to IFN-a.
Eflect of protein synthesis and PKC inhibitors on IFN-in-
duced spectrin reorganization. Results demonstrating that maximal spectrin reorganization occurs after exposure to use only. IFN-a for greater than 6 hours suggested that new protein synthesis may be involved in this process. To determine the requirement for new protein synthesis during IFN-a-induced reorganization of spectrin, B-CLL cells from six patients were incubated for 1 hour with 15 pg/mL of cycloheximide before the addition of 200 IU/mL IFN-a and the intracellular organization of spectrin was determined 24 hours later (Fig 6) . After exposure to IFN-a alone, approximately 35% of the total B-CLL cell population exhibited focal accumulations of spectrin in these patient samples. Cycloheximide consistently abrogated the capacity of IFN-a to increase the focal distribution of spectrin in leukemic B cells, indicating that spectrin reorganization triggered by IFN-a was dependent on new protein synthesis. Calphostin C, a specific inhibitor of PKC activity,22 also inhibited the IFN-induced formation of spectrin aggregates in B-CLL cells (Fig 6) . Similar results were obtained using the PKC and PKA inhibitor H-7 (data not shown). The results shown in Fig 6 further demonstrate that IFN-y was as effective as IFN-a in altering the intracellular localization of spectrin in leukemic B cells.
The total cellular content of spectrin in B-CLL cells was determined by Western blot analysis immediately after cells were isolated
IFN-a increases spectrin content in B-CLL cells.
from the peripheral blood or following culture for 24 hours in the absence or presence of 200 IU/mL of recombinant IFN-a (Fig 7) . In this experiment, equivalent amounts of protein were loaded on a 10% polyacrylamide gel, as confirmed by Coomassie blue patterns of duplicate samples (Fig  7a) , and then transferred to nitrocellulose and probed with anti-spectrin antiserum (Fig 7b) . Scanning densitometry analysis indicated that exposure to IFN-a in vitro increased the total amount of the 240-Kd a spectrin band in leukemic B cells by approximately twofold compared with untreated cells. Immunofluorescence analysis of identical samples indicated that focal accumulations of spectrin were observed in 2.0% of freshly isolated cells, 7.0% of cells cultured in medium alone, and 27.2% of cells exposed to IFN-a ( Table  2 , patient 1). Analysis of the intracellular spectrin content in two additional CLL patients after incubation for 24 hours in the presence or absence of 200 IU/mL of IFN-a further indicated that IFN-a increased the total cellular content of spectrin by greater than twofold in these B-CLL cells (Table  2) . Because the data shown in Figs 1 through 6 suggest that IFN-a does not affect the organization of spectrin in every cell within an individual patient sample, the measurement of the total cellular content of spectrin may in fact underestimate the effect of IFN-a on spectrin content. These results indicate that the reorganization of spectrin detected by immunofluorescence in B-CLL cells correlates directly with an increased cellular content of this cytoskeletal protein.
DISCUSSION
Changes in the organization and synthesis of cytoskeletal proteins have been associated with fundamental cellular responses to a variety of external and internal signals. We have shown here that IFN-a induces changes in the subcellular organization of the cytoskeletal protein spectrin in peripheral blood B lymphocytes from normal individuals and in leukemic B cells from CLL and HCL patients. Incubation of both normal and malignant B cells with IFN-a resulted in a marked increase in the number of cells in which spectrin was distributed in a concentrated loci instead of the typical diffuse pattern. The effect of IFN-a on spectrin distribution in B cells occurred in a time and dose-dependent manner and focal accumulations of spectrin were maintained for periods up to 48 hours during continuous exposure to IFN-a.
The biologic or therapeutic result of these effects of IFNa on spectrin distribution in normal and leukemic B cells remains to be determined. One possibility is that a cytoskeletal reorganization relates to the recirculation or extravasation potential of B lymphocytes. In previous studies, IFN-a and IFN-y have been shown to alter the recirculation of B and T lymphocytes in murine and sheep models.10~'1~26~27 In these studies, marked lymphopenia was observed within 24 hours of systemic administration of IFN-a and was associated with the increased uptake and retention of lymphocytes in lymph nodes. IFN-a has also been shown to cause a rapid decrease in the number of leukemic B-CLL and B-HCL cells in the circulation during
In erythrocytes, spectrin is thought to play a major role in red blood cell recirculation because of its ability to regulate plasma membrane fluidity and deformability." A similar relationship between the oruse only. IFN-a influences membrane fluidity3'x3* and possibly alters the recirculation of normal and malignant B cells.
The molecular mechanism or cellular pathway by which IFN-a acts to cause distinctive changes in the subcellular organization of spectrin is unknown; however, several possibilities seem tenable. Studies in which cycloheximide abrogated the IFN-induced focal accumulation of spectrin suggest that this process involves new synthesis of spectrin or some other protein, possibly a chaperone protein, which may be required for the movement of spectrin within a cell. It is noteworthy in this regard that the 70-Kd heat shock protein that functions as a molecular chaperone in some systems33 has been found in spectrin aggregates in murine lymphoc y t e~.~~ Evidence that IFN-a increased the total spectrin content in B-CLL cells by greater than twofold suggests that localization of spectrin immunofluorescence in concentrated regions within B lymphocytes may represent sites of ongoing spectrin synthesis. However, this is unlikely to be the sole explanation for the observed effect of IFN-a on spectrin distribution because focal accumulations of spectrin are found in regions not normally associated with new protein synthesis (eg, plasma membrane associated caplike structures). Moreover, incubation of B lymphocytes with IFN-a was found to result in a sustained loss of the ring-type plasma membraneassociated spectrin staining pattern, as well as a decrease in the diffuse staining pattern, suggesting that mobilization of pre-existing spectrin from cytoplasmic and plasma membrane sites also occurs in response to IFN-a.
Another possible mechanism by which IFN-a may affect spectrin is suggested by the data showing that the PKC inhibitor calphostin C blocked the IFN-a-induced formation of focal accumulations of spectrin. These data imply that the effects of IFN-a on spectrin distribution may involve changes in PKC activity. Work by others has already shown that IFNa activates specific PKC isoenzymes in B lymphoblastoid and epithelioid cell line^.^'.^^ Specifically, IFN-a causes the rapid translocation of specific PKC isoforms from the soluble use only. IFN-a ALTERS SPECTRIN DISTRIBUTION IN B CELLS   765 to the particulate, detergent-insoluble subcellular fraction in both the Daudi B lymphoid and the HeLa epithelioid cell line^.^^"^ Several previous reports from our group have shown that lymphocyte cell surface events that affect PKC activation can rapidly and significantly alter the subcellular localization of spectrin?0,2' Moreover, in murine T cells and B cells we have observed a close positioning between the PKC 81 isoform and focal accumulations of spectrin that occur naturally among tissue lymphocytes and that treatments (such as activation via the antigen receptor or phorbol esters) that cause a change in the distribution and solubility of spectrin cause identical changes in PKC 81:' From these data, we speculate that the changes in the distribution of spectrin induced by IFN-a could reflect changes in the activation state or solubility of PKC, although the delayed kinetics of the spectrin response to IFN-a described in this report compared with our earlier work suggest that it is unlikely to be an immediate result of the engagement of the IFN-a cell surface receptor.
Future studies that define the specific molecular mechanisms by which IFN-a regulates spectrin synthesis and organization in normal and malignant B lymphocytes are expected to provide important insight into the biologic mechanism of action of IFN-a. Moreover, recent studies have determined that the erythroid a spectrin gene is tightly linked to a gene cluster consisting of IFN-activated genes on distal The intracellular spectrin organization was determined by indirect immunofluorescence microscopy after incubation of E-CLL cells for 24 hours in the presence or absence of 200 IU/mL of IFN-a.
t The relative-fold increase in intracellular spectrin concentration was determined by scanning densitometry of Western immunoblots.
mouse chromosome 1, suggesting the possibility that coordinated transcriptional regulation of these genes may be mediated by a common enhancer Therefore, it will also be of interest to determine if the gene for lymphocyte spectrin is similarly linked to IFN stimulated genes.
